Georgina H. Cornish

BioPharmaceuticals R&D, AstraZeneca
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers.

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 12, 2024

Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies.

Immune safety challenges facing the preclinical assessment and clinical progression of cell therapies.

Journal: Drug discovery today

Published: April 08, 2024

Organoid models: the future companions of personalized drug development.

Organoid models: the future companions of personalized drug development.

Journal: Biofabrication

Published: November 30, 2023

CD4+ T cell memory is impaired by species-specific cytotoxic differentiation, but not by TCF-1 loss.

CD4+ T cell memory is impaired by species-specific cytotoxic differentiation, but not by TCF-1 loss.

Journal: Frontiers in immunology

Published: February 17, 2023

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Journal: Research square

Published: September 28, 2021

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Journal: Nature cancer

Published: August 23, 2021

Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases.

Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases.

Journal: Med (New York, N.Y.)

Published: February 25, 2021

E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion.

E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion.

Journal: Oncogene

Published: January 11, 2021

Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein.

Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein.

Journal: EMBO molecular medicine

Published: October 07, 2020

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.

Journal: Science (New York, N.Y.)

Published: July 31, 2020

Default polyfunctional T helper 1 response to ample signal 1 alone.

Default polyfunctional T helper 1 response to ample signal 1 alone.

Journal: Cellular & molecular immunology

Published: October 20, 2019

Phosphatase PTPN22 Regulates Dendritic Cell Homeostasis and cDC2 Dependent T Cell Responses.

Phosphatase PTPN22 Regulates Dendritic Cell Homeostasis and cDC2 Dependent T Cell Responses.

Journal: Frontiers in immunology

Published: September 27, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026